GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75F40121C00109UNIVERSITY OF CALIFORNIA, LOS ANGELES

Overview

Award facts

Net obligations
$2.81M
$2,814,105of $2.81M potential value
Outlays (paid to date)
$2.62M
$2.62M paid of $2.81M obligated$2,617,118
Period of performance
Aug 27, 2021 to Sep 30, 2026
Ended
Modifications
5
Latest action Mar 3, 2026
Contract type
Definitive contract
PIID 75F40121C00109

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60

Dates and value

Award date
Signed on Aug 27, 2021
Potential end of performance
Sep 29, 2026
Current value
$2,814,105Base and exercised options
Potential value (if all options are exercised)
$2,814,105

Obligations by fiscal year of action

  • FY2021: $2,814,105

Total across 1 fiscal year: $2,814,105

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 3, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationLOS ANGELES, CA
UEIRN64EPNH8JC6
CAGE code4B557
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity

Business types and certifications

Educational institutionU.S. government entity

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Biologics; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20993-0002
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Basic researchBR
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
FDABAA-21-00123
Solicitation date
Nov 20, 2020
Notices

Contract details

Subcontracting plan
Plan not included - no subcontracting possibilitiesA
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 27, 2021Base obligation at award: $2,814,105
Latest action
Mar 3, 2026 — Other administrative actionModification P00005; administrative: no change in scope or value
Actions by type
  • Base award1
  • Other administrative action5
6 actions recorded, Aug 27, 2021 to Mar 3, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Closely associatedCL
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Other U.S. entity (e.g. government)B
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
6

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2021/2021-0600-000
  • 075-X-0600-000
Object classes
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression